We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Menopause Can Increase Risk of Metabolic Syndrome

By HospiMedica International staff writers
Posted on 14 Jul 2020
A new study identifies menopause as a risk factor for the development of metabolic syndrome (MTS) or its components, such as hypertension and high blood sugar. More...


Researchers at St. Michael’s Hospital (Toronto, Canada), the University of Toronto (Canada), and other institutions conducted a cross-sectional analysis of 12,611 women (45 to 85 years of age) who participated in the Canadian Longitudinal Study on Aging Comprehensive Cohort in order to evaluate menopause as an independent risk factor for development of MTS or any one of its components, including hypertension, central obesity, dyslipidemia, or elevated glycated hemoglobin.

The results revealed that 79.6% of the women had undergone menopause. The prevalence of MTS was higher (38.2%) among postmenopausal women, compared to 23.2% in premenopausal women. After adjusting for age, body mass index (BMI), and other covariates, menopausal women had a significantly higher relative risk of MTS, when using criteria with a lower waist circumference. Menopause was also associated with a higher risk of impaired glucose tolerance, elevated blood pressure, and elevated triglycerides. The study was published on June 29, 2020, in Menopause.

“These results reaffirm the previously identified link between menopause and metabolic syndrome,” said Stephanie Faubion, MD, medical director of The North American Menopause Society (Pepper Pike, OH, USA), who was not involved in the study. “Given the increased cardiovascular risk associated with metabolic syndrome and that heart disease remains the number one killer of women, this study highlights the importance of cardiovascular risk assessment and risk reduction strategies in midlife women.”

Menopause describes the permanent cessation of the primary functions of the human ovaries, including the cessation of estradiol and progesterone endocrine hormone production. The menopausal transition can be divided into three stages. During pre-menopause, the menstrual cycle becomes irregular; this stage begins 5-10 years before menopause. Perimenopause is the transition period prior to menopause, when the function of the ovaries noticeably fades away, leading to cessation of menstruation. Post-menopause is the time after the last menstruation.

Related Links:
St. Michael’s Hospital
University of Toronto



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
New
Pediatric Cast Saw
CSP-201 Quietcast
New
Dual Chamber Warming Cabinet
D-Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The Minder Implant can record brain activity continuously for very long periods (Photo courtesy of Epiminder)

Implantable Device Continuously Monitors Brain Activity in Epileptic Patients

Epilepsy is one of the most prevalent and serious chronic neurological disorders, impacting around 52 million people globally. It is characterized by recurrent seizures, which are caused by abnormal electrical... Read more

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.